AHSG and metabolic dysfunction-associated steatotic liver disease: In the overall study population, Fetuin-A was positively associated with CAD (Beta coefficient 131.36, SE 16.52; p < 0.001) and NAFLD (Beta coefficient 34.63, SE 16.44; p = 0.037).